Published on 29 February 2016
Oncodesign, founded in Dijon in 1995, actively engages in searching for new therapies against cancer and other serious illnesses with no effective treatment to serve the pharmaceutical industry. After joining the Alternext market of Euronext in Paris in 2014 to strengthen its discovery activities, the company established a new partnership with a major pharmaceutical laboratory, Bristol-Myers Squibb, with which a major strategic collaboration started.
Read more